BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1212267)

  • 1. Tight-binding inhibitors-II. Non-steady state nature of inhibition of milk xanthine oxidase by allopurinol and alloxanthine and of human erythrocytic adenosine deaminase by coformycin.
    Cha S; Agarwal RP; Parks RE
    Biochem Pharmacol; 1975 Dec; 24(23):2187-97. PubMed ID: 1212267
    [No Abstract]   [Full Text] [Related]  

  • 2. Tight-binding inhibitors--III. A new approach for the determination of competition between tight-binding inhibitors and substrates--inhibition of adenosine deaminase by coformycin.
    Cha S
    Biochem Pharmacol; 1976 Dec; 25(24):2695-702. PubMed ID: 1008893
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
    Parks RE; Dawicki DD; Agarwal KC; Chen SF; Stoeckler JD
    Ann N Y Acad Sci; 1985; 451():188-203. PubMed ID: 3878117
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of maturation of human precursor lymphocytes by coformycin, an inhibitor of the enzyme adenosine deaminase.
    Ballet JJ; Insel R; Merler E; Rosen FS
    J Exp Med; 1976 May; 143(5):1271-6. PubMed ID: 1262787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on inhibition of adenosine deaminase by isocoformycin in vitro and in vivo.
    Shimazaki M; Kumada Y; Takeuchi T; Umezawa H; Watanabe K
    J Antibiot (Tokyo); 1979 Jun; 32(6):654-8. PubMed ID: 468739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 6,9-disubstituted 8-azapurines on adenosine deaminase, guanine deaminase and xanthine oxidase.
    Lucacchini A; Bazzichi L; Biagi G; Livi O; Segnini D
    Ital J Biochem; 1982; 31(3):153-62. PubMed ID: 6897062
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
    Smith CM; Belch A; Henderson JF
    Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells.
    Agarwal RP
    Biochem Pharmacol; 1980 Feb; 29(2):187-93. PubMed ID: 6965857
    [No Abstract]   [Full Text] [Related]  

  • 9. Study on the inhibition of adenosine deaminase.
    Montgomery JA; Thomas HJ; Zell AL; Einsphar HM; Bugg CE
    J Med Chem; 1985 Nov; 28(11):1751-3. PubMed ID: 4068002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Mitchell BS; Koller CA; Kelley WN
    Adv Exp Med Biol; 1979; 122B():347-50. PubMed ID: 317568
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of allopurinol (4-hydroxyprazolo(3,4-d)pyrimidine) on xanthine accumulation by milk xanthine oxidase in vitro.
    Jezewska MM
    Eur J Biochem; 1974 Jul; 46(2):361-5. PubMed ID: 4408204
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of hypoxia on the guinea-pig myocardium following inhibition of adenosine deaminase by coformycin.
    Szentmiklósi AJ; Németh M; Cseppentö A; Szegi J; Papp JG; Szekeres L
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):287-94. PubMed ID: 6476984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tight binding inhibitors--VIII. Studies of the interactions of 2'-deoxycoformycin and transport inhibitors with the erythrocytic nucleoside transport system.
    Rogler-Brown T; Parks RE
    Biochem Pharmacol; 1980 Sep; 29(18):2491-7. PubMed ID: 6968561
    [No Abstract]   [Full Text] [Related]  

  • 14. ATP depletion as a consequence of adenosine deaminase inhibition in man.
    Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxyadenosine triphosphate accumulation in erythrocytes of deoxycoformycin-treated mice.
    Smith CM; Henderson JF
    Biochem Pharmacol; 1982 Apr; 31(8):1545-51. PubMed ID: 6980005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine and hypoxic vasodilatation.
    Dóra E
    J Cereb Blood Flow Metab; 1985 Dec; 5(4):621-4. PubMed ID: 3877069
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzyme inhibition titration assay for 2'-deoxycoformycin and its application to the study of the relationship between drug concentration and tissue adenosine deaminase in dogs and rats.
    Chassin MM; Adamson RH; Zaharevitz DW; Johns DG
    Biochem Pharmacol; 1979 Jun; 28(12):1849-55. PubMed ID: 454456
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxicities of adenosine and 2'-deoxyadrenosine in L cells treated with inhibitors of adenosine deaminase.
    Lapi L; Cohen SS
    Biochem Pharmacol; 1977 Jan; 26(1):71-6. PubMed ID: 299815
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of ADA inhibition on B cell differentiation in the rat.
    Barton RW
    Adv Exp Med Biol; 1986; 195 Pt A():525-9. PubMed ID: 3524140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.